0000950170-24-021131.txt : 20240227
0000950170-24-021131.hdr.sgml : 20240227
20240227161028
ACCESSION NUMBER: 0000950170-24-021131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLISON R DIRK
CENTRAL INDEX KEY: 0001253500
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34504
FILM NUMBER: 24686769
MAIL ADDRESS:
STREET 1: 2525 WEST END AVE STE 600
STREET 2: C/O RENAL CARE GROUP INC
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Addus HomeCare Corp
CENTRAL INDEX KEY: 0001468328
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 205340172
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6303 COWBOYS WAY
STREET 2: SUITE 600
CITY: FRISCO
STATE: TX
ZIP: 75034
BUSINESS PHONE: 469-535-8200
MAIL ADDRESS:
STREET 1: 6303 COWBOYS WAY
STREET 2: SUITE 600
CITY: FRISCO
STATE: TX
ZIP: 75034
4
1
ownership.xml
4
X0508
4
2024-02-23
0001468328
Addus HomeCare Corp
ADUS
0001253500
ALLISON R DIRK
6303 COWBOYS WAY
SUITE 600
FRISCO
TX
75034
true
true
false
false
CEO and Chairman
true
Common Stock
2024-02-23
4
A
false
34568
0.00
A
87418
D
Common Stock
2024-02-26
4
S
false
8021
85.95
D
79397
D
The shares vest in equal installments on each of February 23, 2025, February 23, 2026, and February 23, 2027, subject to customary provisions for continued service and acceleration on a change in control.
This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.94 to $85.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
/s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison
2024-02-27